Elevated hyaluronan levels in patients with rheumatic mitral stenosis and pulmonary arterial thromboembolism

Heart Lung Circ. 2014 Jul;23(7):649-54. doi: 10.1016/j.hlc.2014.01.011. Epub 2014 Jan 29.


Introduction: The role of hyaluronan (HA) was previously demonstrated in patients with idiopathic pulmonary arterial hypertension (PAH). Mitral stenosis (MS) and pulmonary arterial thromboembolism (PTE) are important health problems that can cause pulmonovascular pathology. Pulmonary arterial hypertension develops especially in untreated patients with severe MS and most of patients with PTE. However, there is no data about HA levels in patients with MS and PTE. In this study, we investigated HA levels in patients with rheumatic MS and PTE.

Method: Study population was divided into three groups. MS group consisted of 18 patients with moderate or severe MS. PTE group consisted of 16 patients with PTE. Control group consisted of 15 subjects without cardiac and pulmonary disease. Percutaneous mitral balloon valvuloplasty (PMV) was performed on all patients in MS group. Mitral gradients and systolic pulmonary arterial pressure (sPAP) were measured in all patients. HA levels were measured at baseline and first month after PMV.

Results: Mean sPAP±SD (mmHg) was 23±3 in the control group, 44±9 in the MS group and 66±11 in the PTE group (p<0.001). Baseline serum HA levels were significantly correlated with sPAP(echo) (r=0.332 p=0.03) and sPAP(cath) (r=0.559, p=0.007). Serum HA levels (ng/ml) in MS were significantly higher compared to controls [39±14 vs 24±11; p=0.01]. Patients in PTE group had the highest HA levels (61±21; p<0.001). Serum HA levels were significantly decreased at the first month after PMV in patients with MS [MS group: 39±14 (ng/ml), after PMV: 31±8; p=0.03].

Conclusion: This is the first article showing that both MS and PTE can cause increased serum HA levels. HA levels were decreased with PMV procedure in patients with MS.

Keywords: Hyaluronan; Percutaneous mitral balloon valvuloplasty; Pulmonary arterial hypertension; Pulmonary arterial thromboembolism; Rheumatic mitral stenosis.

Publication types

  • Clinical Trial
  • Comparative Study
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Aged
  • Female
  • Humans
  • Hyaluronic Acid / blood*
  • Male
  • Middle Aged
  • Mitral Valve Stenosis / blood*
  • Mitral Valve Stenosis / complications
  • Mitral Valve Stenosis / surgery
  • Pulmonary Artery / surgery
  • Pulmonary Embolism / blood*
  • Pulmonary Embolism / complications
  • Pulmonary Embolism / surgery
  • Rheumatic Heart Disease / blood*
  • Rheumatic Heart Disease / complications
  • Rheumatic Heart Disease / surgery


  • Hyaluronic Acid